BIOGENA • Investment story • Direct digital investment

BIOGENA investment story

A family business becomes a health group. What began for BIOGENA as a family-run micronutrient company is today a health group with more than 120 million euros in revenue.

Since 2015, many investors have accompanied this journey through Invesdor. Since then, BIOGENA has carried out 16 financing rounds via Invesdor. In total, more than 17 million euros in growth capital flowed into the company. BIOGENA is now carrying out a share issue and preparing for a listing on the Direct Market Plus (Vienna MTF) of the Vienna Stock Exchange. This makes BIOGENA an example of direct digital investment in a real company that has developed step by step and is now entering the capital market.

Direct digital investment: the role of Invesdor investors

Between 2015 and 2022, BIOGENA carried out a total of 16 financing rounds via Invesdor. During this period, investors provided more than 17 million euros in growth capital through Invesdor.

This path is characterized by:

1

Long-term partnership

BIOGENA did not choose this form of financing only once, but repeatedly, adapted to each respective growth phase.

2

Direct participation for many instead of a few

Private and smaller professional investors were able to participate at an early stage, with amounts suited to their personal situation. Over the years, this created a broad circle of supporters.

3

Strong European roots

A significant share of the investments came from Germany, Austria and other European countries — the same markets in which BIOGENA is also gaining customers. Since 2015, around 2,100 investors have invested in BIOGENA through Invesdor. On average, investments amounted to around 7,300 euros per person. Depending on the round, the interest rates of the individual bonds ranged from 3.75% to 6.00% per year. All investments were repaid to investors on schedule and in full.

For many people in Germany, Austria and other European countries, BIOGENA therefore offered an opportunity to participate directly in a medium-sized health company and follow its development over several years.

What BIOGENA has achieved so far

The capital market prospectus for the current share issue describes BIOGENA’s starting position with clear figures. For the 2024/2025 financial year, the Biogena Group reports, among other things:

• group revenue of around 124.9 million euros
• historical EBITDA of around 19.1 million euros
• an EBITDA margin of around 15.3 percent
• group equity of around 298.9 million euros

BIOGENA offers more than 400 products and works with around 30,000 doctors and therapists. The company serves customers in around 70 countries and has more than half a million registered members in the BIOGENA Club. According to the prospectus, BIOGENA already has a production capacity built for revenues of around €500 million, which is currently only partially utilized. These figures and structures show an established company with audited financial statements, international reach and a clear focus on prevention and health.

Why the step onto the stock exchange is a logical one

Against this background, the planned step onto the stock exchange is a logical next step for BIOGENA. An IPO enables further equity capital for growth, for example for internationalization, product development, digitalization and new locations.

It creates additional visibility and trust in a regulated environment.

It enables a broader distribution of ownership, into which existing investors can also place themselves as part of their own decisions. For many years, BIOGENA relied on direct financing via Invesdor. This phase helped expand the production capacity, broaden the market and strengthen digital channels. The now planned listing on Direct Market Plus of the Vienna Stock Exchange adds the capital market level to this path.

Context for investors

What investors gain from this now

For people who have already financed BIOGENA through Invesdor, the current development is an important milestone. They can see that a family business has become a health group with revenue well above 120 million euros. All BIOGENA investments placed via Invesdor were repaid as agreed.

• The company has reached a stage where a stock exchange listing can be carried out.

For investors who are only now getting to know BIOGENA, a different perspective emerges: this is a company with a clear market position and tangible products.

• The development of recent years and the current situation are presented transparently in the prospectus.

In both cases, the share issue opens up the opportunity to assess whether and in what form participation in the next stage of the BIOGENA story fits into one’s own investment concept. All information on the current share issue, the use of proceeds and the risks can be found in the capital market prospectus and on BIOGENA’s information page.

Current share issue

Further information on the current BIOGENA share issue

All information on the current share issue, the documents and further details can be found directly on BIOGENA’s information page.

To the BIOGENA share issue

The link opens BIOGENA’s information page in a new tab.

Notes and risks

This text provides information about BIOGENA’s development and the role of Invesdor investors. It does not constitute investment advice and is not an invitation to buy or sell securities. Invesdor does not provide investment brokerage in this context.

The basis for an investment decision is exclusively the published capital market prospectus and the documents of the issuer. Investments in securities and corporate participations involve significant risks, including the complete loss of the capital invested.

The post How Direct Digital Investing can pave the way to the Stock Market first appeared on Invesdor - Blog.

How do investments in healthcare help close gaps in care while also generating returns?  MedTech and healthcare investments are among the most stable and at the same time most innovative segments of the global healthcare market.   

MedTech and healthcare investments refer to capital allocated to companies that develop and commercialize medical technologies, digital health solutions, or healthcare infrastructure.

While many markets are subject to strong fluctuations, the demand for medical and healthcare services remains constant. It continues to grow with an aging population, increasing life expectancy  (according to the Deloitte Global Health Care Outlook 2025 the number of people over 65 in Europe will increase by around 30% by 2030) and the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions.  

This demographic shift increases the pressure on healthcare systems and raises demand for efficient, technology-driven solutions.  

At the same time, healthcare systems are reaching their limits: hospitals are struggling with overload, waiting times are increasing, and modern diagnostics are not available to everyone. This is where new business models and medical technologies come into play. They create access where gaps previously existed and improve processes that have so far been inefficient.

For investors, this creates unique opportunities: MedTech and healthcare investments at Invesdor combine social impact with attractive return potential. Investors support concrete solutions with measurable impact.

Through Invesdor, investors gain access to MedTech and healthcare companies that have already overcome key hurdles and are preparing for the next stage of scaling. These projects combine societal impact with financial prospects. They are also aligned with the United Nations Sustainable Development Goals (SDGs).

MedTech & Healthcare Investments at a Glance  

MedTech and healthcare investments involve companies that improve medical care while building on robust business models.

In Europe, more than 90% of the MedTech sector consists of small and medium-sized enterprises (SMEs). This structure opens attractive opportunities for investors to enter early. At the same time, it requires a solid understanding of development stages, as smaller providers are more dependent on regulatory processes and scaling dynamics.

Germany, Switzerland, and the Netherlands are among the world’s most innovative locations.
Many companies here have overcome significant challenges: they are CE-certified, have completed clinical trials, or have generated their first revenue.  

Challenges and opportunities for Europe’s MedTech market   

According to the industry report   MedTech Europe Facts & Figures and MedTech Europe Facts & Figures 2024 the European medical technology market has been growing steadily at around 5% per year for several years.
 
Unlike traditional early-stage startups, many companies in this sector have already overcome key challenges: they are CE-certified, have completed clinical trials, or have generated initial revenues.  

For investors, this means they typically enter after this phase while still benefiting from significant scaling potential.

Typical segments include:  

• MedTech: devices, implants, and digital tools for diagnostics and therapy  
• Healthcare infrastructure: for example modern diagnostic systems and equipment fleets that hospitals can use and finance flexibly
• Digital Health:  telemedicine, platforms, and wearables 
  
  

Good to know: MedTech

• There are around 38,000 MedTech companies in Europe, about 90% of which are small and medium-sized enterprises (SMEs).
  
• The MedTech sector is one of the most innovative industrial sectors,  accounting for 
  about 8% of all industrial patent applications in Europe. 
  
• MedTech contributes significantly to the economy in terms of employment, exports, and innovation. The European MedTech industry directly employs more than 930,000 people. 
  
• The European MedTech market is estimated at around €170 billion for 2024, representing 
  about 26.4% of the global market. 

(Sources: MedTech Europe Employment & Companies , MedTech Europa Market , MedTech Europe Facts & Figures)  )

Health, innovation, and sustainability: Why Invesdor focuses on MedTech and Healthcare Investments 

According to an analysis by Deloitte („Europe’s MedTech Attractiveness“, 2025, Europe’s MedTech Report 2024) Europe is one of the most attractive regions for MedTech investments. In addition to a strong regulatory framework and excellent research, well-connected innovation clusters form the backbone of the European healthcare market.  

These innovation clusters include in particular the Nordic countries. Finland has developed into a leading location for MedTech start-ups. You can learn what enables this success in the article „8 Reasons for the Success of Finnish MedTech Companies“  

Health as a Growth Engine of the European Economy  

The EFPIA report “The Case for Investing in a Healthier Future for the European Union” also shows that every euro invested in the healthcare sector leads to higher quality of life, lower disease costs, and a more resilient economy in the long term. EFPIA concludes that health should be viewed not merely as a cost factor but as a driver of economic growth.

The European MedTech sector is strongly export-oriented. According to MedTech Europe 2024, around 60% of global medical technology exports originate from Europe. For investors, this means stable international demand, currency diversification, and growth beyond national markets.

Sustainability and Regulation Are Becoming More Important 

Invesdor views health as a central pillar of sustainable investments. Medical innovation directly improves the lives of millions of people while creating scalable business models. Every funding request is reviewed before being listed on our platform. The connection to the UN Sustainable Development Goals (SDGs) plays an important role. Depending on the project, the following goals are particularly relevant:

Good Health and Well-being (SDG 3)

MedTech and healthcare projects improve patient care. Modern diagnostics, digital systems, and new therapies enable earlier treatment and increase the chances of recovery. Every investment in this field directly contributes to improving health and quality of life.

Gender Equality (SDG 5)

Many MedTech and healthcare projects specifically address the needs of women in healthcare. From innovations in neonatology to technologies for female-specific diseases, solutions are emerging in areas that have long been neglected. Investments in such projects strengthen gender equality in healthcare and improve care for female patients.

Affordable and Clean Energy (SDG 7)

Energy efficiency also plays a role in healthcare. Modern devices and digital systems are increasingly designed to consume less electricity and to function reliably even in regions with unstable energy supply. For investors, this means supporting companies that use sustainable technologies while reducing costs for hospitals and patients.

Industry, Innovation and Infrastructure (SDG 9)

Healthcare investments promote modern technologies and the expansion of medical infrastructure. This includes robotic support systems, digital platforms, and flexible diagnostic solutions. Investors support companies that transform research innovations into market-ready products.

Reduced Inequalities (SDG 10)

Many healthcare projects make high-quality care accessible to more people. Pay-per-use models or mobile devices help hospitals in regions with weaker infrastructure. Investments therefore contribute to greater equality in healthcare systems.

Responsible Consumption and Production (SDG 12)

More and more companies are developing MedTech solutions that are resource-efficient and durable. They rely on reusable components and efficient production processes. Investors thus promote both medical impact and responsible resource management.

Partnerships for the Goals (SDG 17)

Progress in healthcare emerges through collaboration. Start-ups, hospitals, universities, and investors work together to bring innovations to market faster. Every investment strengthens this network and amplifies the impact of medical advancements.

We select projects that meet SDG standards. This ensures that investors support robust business models while contributing to solutions that promote ecological, social, and economic sustainability in healthcare. 

Challenges and Opportunities for Sustainable Investments in MedTech and Healthcare 

The healthcare and MedTech sector is considered one of the most exciting areas for investors—stable, innovative, and with clear societal relevance. At the same time, it is complex: regulations, clinical trials, and technological developments determine the pace and involve elevated risks. Investors should understand these mechanisms and be prepared for longer timelines. With foresight, real and sustainable value can emerge.

From Research to Practice: Examples of Successful MedTech Investments

The following examples illustrate different areas of modern MedTech investments. They range from highly specialized diagnostics to digital platform solutions and practical medical aids for everyday life. Each project addresses a clear clinical need, relies on scalable technology, and combines measurable healthcare impact with a sustainable business model. This highlights what matters to investors: evidence-based solutions, transparent milestones, and a clear path to scaling.

Megin: precise brain diagnostics with MEG technology, used worldwide

Megin is a Finnish MedTech company specializing in magnetoencephalography (MEG). This technology measures the magnetic fields generated by electrical signals in the brain, enabling physicians to analyze brain activity in real time.

This is particularly helpful for complex neurological conditions such as epilepsy or brain tumors. More precise diagnostics simplify the planning of surgeries and therapies.

Megin was founded in 1989 and is headquartered in Helsinki. The company is one of the global leaders in MEG technology. More than 120 systems are already installed in hospitals and research institutions. According to the company, it holds over 80% market share in new MEG system installations.

Clinical need and solution: precise mapping of brain function

Neurological diseases often present medicine with a precision challenge. For many procedures, it is crucial to accurately locate specific brain regions. 

Megin’s TRIUX Neo system measures the weak magnetic fields produced by neuronal activity. This allows functional brain areas to be visualized with extremely high temporal and spatial resolution. The method is non-invasive and does not involve radiation exposure. 

This information helps physicians plan procedures more precisely and reduce risks. 

Technology and status: established solution in a specialized market

Megin is considered an established provider in a technically demanding segment of medical technology. Its systems are used worldwide in hospitals and research institutions. Patents, specialized technical expertise, and regulatory requirements create barriers to entry for new competitors. At the same time, demand for precise brain diagnostics is increasing as neurological diseases rise globally.

Impact: better diagnostics and more targeted treatments

When physicians can localize brain functions more precisely, surgeries and therapies can be planned more effectively. This helps reduce risks and improve treatment outcomes. This aligns with the sustainability goal SDG 3 “Good Health and Well-being.” Advances in neurological diagnostics contribute to improving patient care in the long term.

Investor benefit: fixed-interest bond with clear terms

The company was financed through a bond. The terms are clearly structured:  

The financing round reached more than €3.5 million and was supported by more than 1,200 investors.

Megin generates revenue through the sale of MEG systems and service contracts for maintenance and operation. These service contracts provide recurring revenue.

Risks and management: investment cycles and regulatory requirements

The market for highly specialized medical technology is characterized by investment cycles. Hospitals often make large equipment decisions on a long-term and project-based basis. In addition, the installation of an MEG system requires specialized infrastructure such as magnetically shielded rooms. Regulatory requirements and production processes also shape the industry. Megin addresses these challenges through decades of industry experience, an installed system base, and international customer relationships.

Megin illustrates how specialized medical technology can combine investment opportunities with medical progress. Hospitals gain access to precise brain diagnostics while investors participate through a structured bond in the further development of this technology.

Pirche: AI-powered platform making organ transplantation more predictable

Pirche develops a digital diagnostics platform for transplant centers and clinical laboratories. After an organ transplant, immunological compatibility often determines how long a transplanted organ remains functional. Pirche focuses precisely on this point. The platform combines genetic typing with AI-driven modeling and supports physicians in identifying risks earlier and managing therapies more precisely.  

The need is significant. Many transplanted organs lose function within five to ten years. For patients, this means additional procedures, intensive treatments, and increased health burdens. Any improvement in donor organ matching and post-transplant care can therefore make a meaningful difference.

Clinical need and solution: better matching and more targeted follow-up care 

In transplant medicine, laboratories and medical teams already compare key parameters such as blood type and HLA markers. However, this information is not always sufficient to reliably estimate long-term risks. Pirche expands this analysis with additional immunological models.

The platform creates individualized immune risk profiles and supports clinical decision-making with advanced analyses. It uses data that is already available in many clinical laboratories, allowing the technology to integrate into existing workflows without requiring additional data collection.

Technology and status: patent-protected, scientifically documented, integrated into hospital IT

Pirche combines genetic typing with AI-based analysis to visualize complex interactions between donor and recipient. The underlying algorithms are protected by patents and have been examined in numerous scientific publications.

The platform has already been used in a large number of patient cases and further developed in collaboration with international hospitals and research institutions. Partnerships with laboratory providers such as Thermo Fisher Scientific and Werfen-Immucor facilitate integration into existing hospital IT systems.  

Impact: better treatment outcomes and more efficient resource use

When risks are identified earlier, follow-up care and immunosuppression can be adjusted more precisely. This can help reduce complications and extend the functional lifespan of transplanted organs. Such progress contributes to SDG 3 “Good Health and Well-being.”

Responsible use of medical resources also plays a role. Donor organs are extremely scarce. More precise matching can help extend their usability and avoid repeated procedures.

In addition, the analysis considers specific risk groups in transplant medicine, such as highly sensitized patients. This can help reduce inequalities in healthcare access.

Investor benefit: participation in a scalable B2B SaaS platform

The financing took place through an equity investment (security). The price per share was €15.85, with a minimum investment of 20 shares. Between 1.07% and 5.15% equity was offered at a pre-money valuation of approximately €36.86 million. In total, 578 investors participated.

The business model is based on software-as-a-service contracts with transplant centers and clinical laboratories. Hospitals access the platform through subscriptions, while partnerships with laboratory service providers enable further integration opportunities. Such models can generate recurring revenue when software becomes permanently integrated into clinical workflows.

The investor base includes experienced entrepreneurs and investors from the healthcare industry, including individuals with backgrounds in biotechnology. These investors contribute not only capital but also industry expertise and networks.

Risks and management: clinical adoption, regulation, and market dynamics

Digital diagnostics in clinical practice requires trust, strong evidence, and seamless integration. Pirche addresses these requirements through scientific documentation, a large number of evaluated cases, and IT partnerships. Nevertheless, the speed at which hospitals adopt new decision-support software into processes and budgets remains a key factor.

Regulatory requirements for healthcare software, particularly AI-based systems, also shape development. Pirche focuses strongly on the US transplant market, which offers opportunities but also introduces certain dependencies.

Pirche demonstrates how digital diagnostics can create value in a highly critical medical field. Hospitals gain a platform for improved risk management, patients may benefit from more stable outcomes, and investors participate in a patent-protected B2B SaaS model with documented usage and a clear commercialization strategy.

STIL: Steady Hands for an Independent Life

STIL  develops an orthosis that stabilizes the hands. A cup of coffee remains steady. A pen produces a readable signature again. A shirt button can be fastened without help. This is exactly where the STIL orthosis helps. It sits lightly on the forearm, specifically dampens tremors, and works immediately. Clinical data shows tremor reduction of more than 80 percent. Users regain control, can perform everyday tasks independently, and feel more confident.

Since 2023, STIL has been in use—first in the Netherlands and now also in Germany, Belgium, and Italy. Medical supply stores and orthopedic partners fit the orthosis and support users, bringing the solution directly into daily life.

Clinical need and solution: effective, practical, immediately available

Tremors significantly limit everyday life. Eating, writing, or dressing becomes difficult. Shame often leads to social withdrawal.

The STIL orthosis mechanically stabilizes the arm. It dampens uncontrolled movements without restricting natural motion. The effect is immediate. No electricity is required. The orthosis is easy to put on and adjust, even at older ages. Medical supply providers and orthopedic specialists support patients locally.

Technology and status: certification and clinical data

The STIL orthosis is CE-certified and FDA-registered. STIL operates under ISO 13485. A clinical study demonstrates its effectiveness for essential tremor, while additional studies are expanding its application to Parkinson’s disease and other movement disorders. The modular design adapts to different sizes and needs. Distribution partners in the Netherlands, Germany, Belgium, and Italy expand market reach. A new AI-based app supports screening and simplifies initial assessments for patients and distributors.

Impact: more independence, lower costs, stronger participation

Reduced tremors allow people to eat, write, and work independently again. This strengthens dignity and participation. Hospitals and insurers benefit from a non-invasive alternative to surgery or long-term medication. The orthosis helps reduce follow-up costs and relieve healthcare systems. It contributes to SDG 3 and, through durable and repairable product design, also supports SDG 9 (Industry, Innovation and Infrastructure), SDG 10 (Reduced Inequalities), and SDG 12 (Responsible Consumption and Production).

Investor benefit: validated technology, rapid distribution, large market

STIL combines medical benefit with a clear go-to-market strategy. Distribution runs through an established network of medical supply stores and orthopedic partners, including Ottobock (Italy), STOLLE (Germany), and VIGO (Belgium). The addressable market in the EU and the US is worth billions. Renowned investors such as Health Innovations, Rabobank, the EIC Accelerator, and the Brain Foundation Netherlands support growth. The latest valuation was €10 million pre-money. The round offered strengthened shareholder rights for new investors and followed a clear exit logic.

Risks and management: reimbursement, adoption, scaling, regulation

Reimbursement pathways vary by market. STIL works with pilot centers, key opinion leaders, and partners to secure coverage. Adoption in daily practice is supported by training, simple fitting processes, and distributor support. Scaling and supply chains are planned step by step with clear quality processes. CE certification, FDA registration, and ongoing studies reduce regulatory uncertainty. The AI screening app improves matching and increases success rates in patient care.

STIL brings a clinically validated, non-invasive solution into standard care. Patients gain independence in daily life. Healthcare providers operate more efficiently. Investors gain access to a scalable MedTech company with a clear distribution strategy, growing partnerships, and strong validation.

Healthcare investments: benefits for people and investors

Investments in MedTech and healthcare combine economic stability with social impact. They allow investors to actively contribute to improving medical care while achieving attractive long-term returns.

MedTech and healthcare projects are a valuable addition to a diversified portfolio. They respond to global megatrends such as demographic change, technological innovation, and the growing demand for efficient healthcare.

For Invesdor, it makes sense to focus on companies that:

develop new medical technologies that improve diagnostics, therapy, or care,
optimize existing systems by digitizing processes or making devices more sustainable, 
expand medical infrastructure, for example through pay-per-use models or mobile solutions,  
scale internationally to bring innovations to new markets more quickly.  

Such projects meet clear sustainability and quality standards and offer strong value creation potential.

The healthcare sector is considered particularly resilient: people require medical services regardless of economic cycles. Healthcare investments therefore offer long-term stability. Companies with CE certifications and validated clinical data increasingly meet strict regulatory requirements, which further strengthens their market position.

MedTech and healthcare offer growth potential through scaling, market expansion into new regions, and possible exits to larger corporations. Investors benefit from the combination of measurable impact, innovation dynamics, and predictable return models—whether through bonds with fixed interest or equity investments with upside potential.

As with any asset class, risks exist. In the MedTech sector, these include potential delays in studies, regulatory changes, or longer approval processes. Liquidity challenges or dilution in follow-up financing rounds can also influence return profiles. Equity investments also carry the risk of partial or total loss.

A structured due diligence process such as the one applied by Invesdor helps reduce these risks.

Projects are evaluated based on financial metrics, clinical evidence, ESG criteria, and sustainability standards. This provides investors with access to vetted, viable, and impact-oriented companies.

An investment in the healthcare sector allows investors to influence the future of medical care. Those who invest in MedTech and healthcare contribute to accelerating innovation, improving patient access to treatment, and strengthening healthcare systems worldwide—while combining this social contribution with a clear economic perspective.

God to know:  How Invesdor selects Healthcare and MedTech projects 

Invesdor reviews every project through multiple stages to ensure quality, transparency, and sustainability:

Only about 5% of submitted projects make it onto the Invesdor platform. Further details about the evaluation process for investment opportunities can be found here: Investment Evaluation Process.

Invest in health now: your chance to actively shape the future! 

Healthcare and MedTech investments combine financial stability with social impact. Investors support innovations that improve lives—from advanced diagnostics and digital health solutions to new medical technologies. At the same time, they benefit from a growth market that is largely independent of economic cycles.

Those who invest in this sector promote progress, improve access to better care, and actively shape the future of medicine.

Discover current investment opportunities on Invesdor:
projects that combine medical progress with economic potential.

Start today and invest in a healthier future! 

The post MedTech and Healthcare Investments: Opportunities, Risks, and Examples first appeared on Invesdor - Blog.

1. Keep a Cool Head 

In economically stormy weather, it’s tempting to react emotionally. However, such reactions are not always beneficial. Market downturns are unpleasant but part of the investing journey. Those who act out of fear often miss the recovery that follows shortly after. In times like these, calmness and patience are your greatest allies. 

2. Diversify – stay close to home

Diversification is essential in any market, but especially when volatility is high. By spreading your investments across different sectors, regions, and types of companies, you limit risk and increase your chance of stable returns. Don’t put all your eggs in one basket — build a well-balanced, resilient portfolio. But diversification doesn’t always mean going global. In fact, focusing on stable, locally rooted companies can be a smart move — especially now. 

That’s why Invesdor offers direct investments in Northern European companies — businesses that are not only based here but also generate most of their revenue within the region. These are companies you can understand, support, and grow with. Unlike many stock-listed multinationals with high exposure to global uncertainty, our companies are anchored in local economies and have a strong regional focus. 

What exactly does investment diversification mean?
The article “Investment Diversification Made Simple” explores key principles in more detail, provides concrete examples, and offers helpful context.

3. Look Beyond the Stock Market

One of the advantages of direct investing is the ability to invest in non-listed, local companies — businesses that are not subject to daily stock market fluctuations and short-term investor sentiment. These companies, often rooted in local European communities, tend to have a long-term focus and sustainable growth ambitions. By supporting them, you’re investing in the strength and resilience of the (Northern) European economy. 

4. Invest in Sustainable Companies

Sustainable businesses — those focused not just on profit but also on people and the planet — often prove more resilient in uncertain times. These companies build for the long term, maintain strong relationships with stakeholders, and take a future-focused approach. Especially now, it’s worthwhile to support businesses that aim to make the world a better place. 

In Conclusion: Think Long-Term 

Economic shocks are often temporary. A well-diversified portfolio, on the other hand, is built to last. Don’t get caught up in the noise of the moment. History shows that markets tend to recover after periods of turmoil. At Invesdor, we help you invest directly in companies that matter — close to home, with a long-term vision. Stay calm, stay close, and invest wisely. 

The post Direct investing in turbulent times: stay calm and diversify  first appeared on Invesdor - Blog.

This is where Liion Power comes in. The clean tech company from Amsterdam develops intelligent charging technologies that significantly extend battery life. 

Its first product, Leo, is a smart plug-and-play USB charger. It charges batteries gently and based on data. Building on this, a scalable software and data platform for electronics manufacturers and e-mobility providers is being developed. 

Liion Power’s goal: extend the usable life of devices while reducing environmental impact, conserving resources, and lowering costs. 

For investors, Liion Power is an exciting opportunity in the fields of energy efficiency, battery technology, and recurring software revenue. 

When batteries die too soon: the environmental impact 

What happens when a battery starts to weaken? It often doesn’t stop with a battery swap. In many cases, the entire device ends up sitting in a drawer for years or goes straight to the trash. The consequences?  

• Increasing amounts of electronic waste 
• High demand for new batteries – and thus raw materials 
• Additional CO₂ emissions from production, transport, and disposal 
• Extra costs for new devices  

The use of lithium-ion batteries is on the rise. They’re found in consumer electronics, e-bikes, e-scooters, tools, and a wide range of connected devices. Global forecasts predict the lithium-ion battery market will reach hundreds of billions by 2030. 

At the same time, the segment for smart charging and battery management solutions is seeing strong annual growth. 

Regulation is also tightening. New EU rules demand greater transparency around battery life and sustainability. Manufacturers must show how durable their products are and how responsibly they manage resources. 

The key question: how can existing battery capacity be better used before producing new cells? 

Liion Power turns simple charging into intelligent battery solutions 

Liion Power was founded in 2021 with the mission to extend battery usability. The approach: don’t just monitor charging – actively manage it.  

Leo: smart plug-and-play charging 

Leo is a device that fits via USB between the power adapter and your device. It extends battery life by: 

• Analyzing the battery of the connected device 
• Adjusting charging limits and speed 
• Planning short charging pauses 
• Reducing stress from fast charging, 100% charging, overnight charging, and preventing high temperatures 

Tests show Leo can increase battery life by up to 63%. Around 4,900 Leo units have been sold across 59 countries. Preorders worth approximately €250,000 confirm market demand. 

Leo is both a product and a data source. Every use provides anonymized insights into real-life charging and battery use.  

From hardware to B2B software platform 

Based on this foundation, Liion Power is developing its technology into a B2B software licensing platform.  

The concept: 

• Liion Power’s algorithms and embedded firmware are integrated directly into manufacturers’ products – such as chargers, e-bikes, headphones, routers, or other IoT devices. 
• Manufacturers can gently charge batteries in their devices, offer customers longer usage times, and improve their sustainability metrics. 
• Liion Power earns revenue through licensing and SaaS models, e.g., per device and per connected system. 

This allows the company to grow from a hardware vendor into a software and data company focused on battery health and energy efficiency. . 

Extended battery life: real-world benefits for users and businesses 

What does smart charging offer in daily life and business operations? The benefits are visible on multiple levels.  

1. Longer use instead of early replacement 

Gentler charging extends battery lifespan. For end users, this means: 

• Devices need to be replaced less often 
• Spending on new hardware decreases 
• Battery issues appear later in the device lifecycle 

For businesses – like e-bike or e-scooter fleet operators – key benefits include: 

• Longer service life of vehicles 
• Less need for battery or device replacements 
• Lower maintenance and service costs  

The simple question is: how many extra years of use can be gained from a battery that’s actively protected?  

2. Less e-waste and lower CO₂ emissions 

If batteries last longer, fewer new ones need to be made. This reduces both e-waste and CO₂ emissions. 

Liion Power estimates that extending battery life by around 50% can save 20 to 30 kg of CO₂ per device. In households with 8 to 10 rechargeable devices, this adds up to 160 to 300 kg of CO₂ savings per household. 

With integration into millions of devices, the emission reduction in the electronics sector becomes significant.  

3. Improved sustainability metrics for manufacturers

Manufacturers face growing pressure to make products more durable and resource-efficient. Consumers and regulators increasingly care about how long devices last. By integrating Liion Power’s software, manufacturers can: 

• Demonstrably extend product life 
• Back up sustainability reports with real data 
• Strengthen their profile as providers of durable and efficient tech  

This helps meet requirements around battery passports, circular economy, and reporting. 

4. Transparency and data-driven decisions 

In the consumer market, users gain insights into battery status and charging behavior via an app. They can see what’s stressing the battery and how its lifespan is developing. 

In business settings, fleet operators and OEMs use dashboards to:  

• Monitor battery health in the field 
• Plan maintenance 
• Reduce failures 

The collected data flows back into the algorithms – improving accuracy with each use. 

From charger to data platform: why smart battery tech and Liion Power matter to investors 

What makes Liion Power interesting is the combination of real-world value and a scalable business model.  

1. A growing sector around lithium-ion batteries 

Lithium-ion batteries are a key technology in the modern economy. As electric mobility, connected devices, and portable electronics become more widespread, so does the need for battery health solutions. 

Liion Power targets the segment where batteries age prematurely due to poor charging. This affects countless existing and future applications – opening up wide potential for smart charging technology. 

2. Dual approach with hardware and software

Liion Power combines two layers: 

• Hardware revenue from Leo in the consumer segment 
• Software and licensing revenue in the B2B segment 

In the short term, Leo builds visibility, customer feedback, and real-world data. In the medium to long term, software licenses and SaaS models offer high margins and international scalability. 

Typical license models include fees per device plus ongoing charges per connected unit, along with integration and support services. 

3. Data as part of the company’s value

Liion Power’s technology collects charging and usage data from real applications. These data: 

• Improve the algorithms 
• Demonstrate value to OEMs and fleet operators 
• Provide an edge over competitors without equivalent data 

This makes data a key value driver for the company. 

4. Strategic partners and experienced shareholders 

Liion Power collaborates with partners such as Init Power and TOP-electronics. TOP-electronics provides access to numerous OEMs in Europe, the US, and Asia – helping integrate the software into existing supply chains. 

The shareholder base includes founders with physics, tech, and entrepreneurial expertise, as well as investors experienced in finance, electronics, and sustainable tech. The founders retain majority voting rights and are committed to long-term value growth. 

5. Impact investing with measurable outcomes 

Liion Power contributes to multiple UN Sustainable Development Goals, including industry, innovation, responsible consumption, and climate action. 

The impact is quantifiable: saved CO₂ emissions, reduced e-waste, and longer product lifespans. For impact-driven investors who want measurable results, this is a strong value proposition. 

6. Potential exit opportunities

As the technology spreads, several exit paths emerge, such as: 

• Acquisition by a player in electronics, battery tech, or e-mobility 
• Sale of technology and IP to a larger industry partner 
• A potential IPO, provided recurring software revenues and international integration scale accordingly 

All scenarios share one thing: the value of Liion Power’s tech and data grows with usage. 

Conclusion: Liion Power in the cleantech market – why it’s worth a closer look 

Liion Power brings several trends together. The technology behind Leo is tested and already on the market. The B2B software platform builds on it and creates the foundation for recurring license and data revenues. The demand for longer-lasting batteries is increasing. Regulation and consumer expectations support solutions that extend product life and conserve resources. 

For those looking to invest in companies tackling clear problems with concrete tech solutions and scalable models, Liion Power offers a compelling, transparent proposition. 

The key question for investors: what role will smart charging play in a world where more and more devices are electric and connected? Liion Power offers an answer that aligns with exactly that development. 

Learn more and invest in smart battery technology now 

Visit the Liion Power investment page 

Disclaimer: Please read the risk disclosures and documents carefully. Investments in securities of growth companies can result in the total loss of invested capital. 

The post Liion Power: smart charging to prevent premature battery death and extend battery life  first appeared on Invesdor - Blog.

PCaVision offers a new way to make diagnostics more efficient, faster, and accessible. The Dutch MedTech company is developing an AI-powered prostate cancer diagnostic tool based on ultrasound, enabling urologists to make a diagnosis in a single session —without MRI and without radiologists. 

In doing so, PCaVision addresses a care gap that is only set to grow in the coming years. That’s why this project is also compelling for investors: it combines medical benefit, impact investing in healthcare, and a scalable SaaS model with strong growth potential.  

Prostate cancer – an urgent health challenge  

A common disease. A diagnosis that takes time and energy. 

Prostate cancer is one of the most frequently diagnosed cancers in men. Global demand for diagnostic procedures is growing by about 10% each year. By 2040, demand is expected to double. Reasons include: 

• An aging population 
• Expanded preventive care programs 
• Growing awareness of prostate cancer screening 

1. Waiting for the exam – often for weeks 

Suspected prostate cancer is stressful. Many patients wait weeks for an MRI appointment due to limited radiology capacity. This creates uncertainty and delays potential treatment.

2. Multiple appointments, more effort

DThe standard process looks like this: 

• Suspicion raised during a urologist visit

• Referral for MRI 

• MRI result from a radiologist 

• Follow-up with the urologist 

• Targeted biopsy 

The result: delays, extra steps, and numerous appointments. 

3.Invasive procedures, often unnecessary 

The alternative to MRI is a systematic biopsy involving multiple tissue samples—even if no clinically relevant cancer is found. This places a physical and mental burden on patients.

4. Capacity issues across the system

Urology and radiology departments are already stretched thin. Overloaded diagnostic structures mean longer wait times  and case numbers continue to rise. 

In short: the system is reaching its limits, and the ones suffering are the men who need clarity. 

PCaVision streamlines the lengthy diagnostic process

PCaVision accelerates diagnosis by combining AI and ultrasound. The technology is clinically validated, CE-certified, and already in use in pilot clinics. 

How does it work in practice?

• The urologist uses a standard 3D/4D ultrasound probe
• PCaVision analyzes the data automatically
• The software generates a color-coded heatmap highlighting suspicious areas

The physician can perform targeted biopsies in the same session

A diagnostic process that used to take weeks is now completed in just 20–30 minutes.  

Benefits for patients: clearer, less stressful, faster diagnosis  

1. Faster diagnosis enables earlier treatment
Many men spend weeks in uncertainty. PCaVision drastically reduces this time. Early, clear diagnoses improve the chances of detecting cancer at a treatable stage.

2. Less physical strain
Targeted biopsies instead of “blind” sampling mean: 

• Fewer punctures
• The physician can perform targeted biopsies in the same session
• Less post-procedure discomfort

Studies show unnecessary biopsies can be reduced by up to 75%. 

3. No additional appointments, everything in one session 
Patients no longer need to wait for MRI slots, organize travel to radiology centers, or coordinate multiple doctor visits. This saves time, reduces stress, and makes the process more predictable. 

4. MRI-level diagnostic quality, but more accessible 
PCaVision matches MRI in detecting clinically relevant tumors, but it’s significantly more affordable and can be used wherever ultrasound is available. 

5. Greater equity in access to care 
In many regions, MRI access is limited. This technology enables diagnostics in places where patients previously faced long waits. For men in rural or underserved areas, that’s a real advantage. 

In short: PCaVision gives patients earlier clarity, reduces their burden, improves access to diagnostics and relieves the pressure on the healthcare system. 

Why this matters to investors 

Because patient benefits are directly tied to economic potential. The bigger the medical problem, the stronger the market and the clearer the need for a better solution. 

1. A large, growing market 
Over 10 million diagnostic procedures globally each year 
Growth: ~10% annually 
By 2040: expected to double 

This is a huge market, and PCaVision addresses a critical bottleneck. 

2. A solution that truly relieves the system 
The technology shortens diagnostic times from weeks to minutes. That means real capacity gains, cost reduction, and higher efficiency. 

For clinics, that translates to: 

• Faster workflows 
• Less dependency on MRI 
• Economic benefits 

A product that cuts costs while improving care quality has strong chances for widespread adoption. 

3. A scalable SaaS business model 
PCaVision earns per scan, not per device. That means: 

• Recurring revenue 
• Predictable income 
• High margins 
• Low variable costs 
• Strong scalability 

Every clinic becomes a long-term revenue driver. 

4. Clinically validated, CE-certified, early customers onboard 
The company is no longer a research project, it’s a product in the market. This maturity reduces tech risk for investors. 

5. Strong institutional backers 
The Series A is supported by: 

• NLC Health Impact Fund 
• CbusineZ 
• TU/e Holding
• Family offices and experienced angel investors 

Private investors participate via Invesdor on the same preferred share terms as these institutional investors, meaning equal economic rights. 

6. Impact investing with measurable value 
This healthcare technology: 

• Speeds up diagnoses 
• Reduces unnecessary procedures
• Improves access to care  
• Relieves pressure on healthcare systems 

… fulfilling SDG 3: “Good Health and Well-being.” 

Investing in PCaVision means tackling a socially relevant problem, with potential for financial upside.

7. Attractive exit options in MedTech 
MedTech companies with strong clinical evidence and scalable models are frequently acquired. Potential outcomes include: 

• Strategic acquisition by imaging or diagnostics giants 
• Series B funding at a higher valuation
• Regional licensing or distribution partnerships 

As market adoption grows, so does company value and investor potential. 

What matters:

Investing in growth companies carries risk, including total loss. 
At the same time, this market often offers a compelling risk-reward ratio. 

A rational checklist: 

• Is the market big enough? → Yes: growing, driven by demographics and medical need 

• Does the company solve a real problem? → Yes: a genuine and growing care gap 

• Is the product validated and market-ready? → Yes: CE-certified, early clinics onboard, strong data 

• Is the business model scalable? → Yes: SaaS with recurring revenue 

• Are experienced investors involved? → Yes: institutional and strategic partners 

For many investors, PCaVision is compelling: it combines medical value, measurable impact, and a scalable tech model, a rare combination in the MedTech space. 

Conclusion: why now may be the right time 

PCaVision is at the intersection of technology, market, and timing. The clinical evidence is strong, early adopters are in place, the product is ready and the healthcare problem is only growing. 

Those looking to invest in companies that: 

• Drive medical progress 

• Address real care gaps 

• Offer clear growth potential 

… will find in PCaVision a project with clear relevance and solid foundations. 

Find out more now and invest in MedTech: your opportunity to help shape the future! 

Visit PCaVision’s investment page 

Disclaimer: Please read the risk disclosures and documentation carefully. Investing in securities of growth companies can result in a total loss of invested capital.

The post Detect prostate cancer earlier: How PCaVision helps patients and appeals to investors  first appeared on Invesdor - Blog.

Social inequality, climate change, and the energy transition– we are facing complex challenges that demand long-term, resource-conscious solutions. Real estate, as one of the largest single asset classes, and largest source of CO2 emissions plays a central role in this context. Real estate is where the largest impact on energy consumption, social inclusiveness, and sustainable economic practices can be found. Real estate shapes how we live, work, and stands for a majority of the energy we consume and CO2 emissions we have. 

For this reason, we at Invesdor have taken the strategic decision to increasingly offer investment opportunities in real estate. These real estate investment opportunities align with our mission to offer both financial and sustainable returns. The vast majority of these investments are closely aligned with at least one of the United Nations’ Sustainable Development Goals (SDGs).   
 
What does sustainable real estate mean? Why does renewable energy sources play such a key role? In this article we will explores these topics and how you as an investor can earn both a financial and sustainable return through Invesdor.  

Real estate, renewable energy, and sustainability: Why is Invesdor expanding its range of investment opportunities into real estate ? 

Invesdor follows a clear strategy: sustainability and financial returns are at the core of the investment opportunities we offer. Through the investment opportunities in corporate debt, equity investments and renewable energy we have been able to offer attractive financial returns together with environmental sustainability. This has allowed our investors to diversify among three asset classes, ultimately reducing risk while maintaining attractive expected returns. We have however identified that social sustainability is an underserved topic in the financial markets. 

By offering our investors with real estate investment opportunities we believe that we can not only allow our investors to have an even larger environmentally sustainable impact but also tap into social sustainability and diversify further through adding a fourth asset class. This is why we have taken the strategic decision to increasingly offer investment opportunities within real estate. 

Our decision to increasingly offer investment opportunities within real estate is a direct reflection of our commitment to the United Nations Sustainable Development Goals (SDGs, https://sdgs.un.org/goals). We emphasize environmental aspects as well as social and economic criteria. Every investment opportunity is assessed in advance using a proprietary checklist. Our minimum requirement is ESG – Environmental, Social and Governance – compliance while we strive for having at least 80% of the investment opportunities SDG.  Key SDGs we focus on include the following:  

• Good Health and Well-Being (SDG 3): Sustainable real estate promotes healthier living and working environments through improved air quality, the use of natural building materials, and modern ventilation systems—contributing to greater well-being for occupants. 

• Affordable and Clean Energy (SDG 7): Buildings that rely on renewable energy sources such as solar power, geothermal energy, and battery storage help reduce CO₂ emissions—and ongoing operating costs.  Invesdor investment projects are examined to determine the extent to which they cover their energy requirement from renewable sources. 

• Reduced Inequalities (SDG 10): Inclusive and socially responsible real estate offers fair access to affordable housing, especially for students, seniors, and low-income households. In the investment opportunities offered at Invesdor this can mean for example socially supported real estate.  

• Sustainable Cities and Communities (SDG 11): Sustainable real estate can for example contribute to the resilience and livability of urban areas through the renovation and repurposing of existing buildings and smart neighborhood solutions. Ultimately having an impact not only on the livability of the community but also on the environment. When evaluating investment opportunities within real estate we consider multiple factors including local context , support mixed-use development, and help shape future-proof urban structures.   

• Responsible Consumption and Production (SDG 12): Sustainable real estate construction relies on resource-efficient construction methods. Such real estate prioritizes the refurbishment of existing buildings and the use of eco-friendly materials. Our assessment criteria for sustainable real estate construction and refurbishment include, for example,  material circularity and long-term maintainability.

Through our strict evaluation criterion including the above-mentioned SDG’s we at Invesdor want to enable our investors to invest in real estate offering attractive financial- and sustainable returns and the opportunity to diversify into a new asset class. 

INFO: What are sustainable buildings?   
Sustainable real estate refers to buildings or neighborhoods that are planned from the outset- or transformed according to environmental, economic, and social criteria. Such buildings can be characterized by resource-efficient construction methods (such as recycled materials and low CO₂ emissions), high energy efficiency (including renewable energy and smart building technology), and socially inclusive usage concepts (such as affordable housing and flexible space layouts). 

Sustainable real estate investments: challenges and opportunities      

The real estate market is undergoing noticeable change: rising energy costs, stricter climate regulations, and the growing demand for sustainable investments are driving the need for new, creative solutions. This affects not only new construction—where sustainable options can be considered in terms of land use, materials, and energy—but also existing buildings, which are renovated and brought up to modern energy standards. 

• Renovation Needs and Energy Efficiency: 
  Many existing buildings no longer meet current energy efficiency standards. Energy renovations can reduce energy consumption by up to 50%, though they require higher upfront investment. Invesdor offers an attractive solution here: private investors can invest comparatively small amounts in the construction- or renovation of sustainable buildings allowing the investors to gain a financial return while also having a positive environmental impact. 

• Stricter Climate Regulations and Compliance: 
  The EU Taxonomy and local national regulation, such as Germany’s Building Energy Act (GEG), require that properties meet specific environmental criteria. This regulation is ultimately expected to lead to an increasing investment need in the real estate sector, allowing investors to earn a financial return while being part of the transition and also earning a environmental return. 

• Growing Demand for Green Properties: 
  Studies show that tenants and buyers increasingly value sustainability features—such as lower CO₂ emissions, access to public transportation, and high energy efficiency. The European Property Market Report highlights that occupancy rates for green buildings in major cities are up to ten percentage points higher than for conventional properties. 
  (Sources: https://www.cbre.com/insights/books/european-real-estate-market-outlook-2024/sustainability, https://www.realestate.bnpparibas.de/sites/default/files/document/2024-03/green-building-investmentmarket-germany-2024.pdf)

• Financial Opportunities and Risks: 
  While sustainable buildings tend to have higher construction costs, they tend to offer long-term savings through lower energy and maintenance expenses. This can reduce the risk of rental vacancies and increases asset stability. At the same time, transaction volume and investor interest in the “Alternative Investments – Sustainable Real Estate” segment rose by 15% in 2024. This reflects a growing desire among investors to diversify beyond traditional equity and bond markets. 
  (Sources: https://www.unepfi.org/wordpress/wp-content/uploads/2024/04/PRB_Banking-on-Green-Buildings_final.pdf, https://www.realestate.bnpparibas.de/sites/default/files/document/2024-03/green-building-investmentmarket-germany-2024.pdf) 

• Invesdor as your partner in real estate investing: 
  Through Invesdor private investors can invest in curated investment opportunities with relatively small amounts. Our investment tickets start as low as 250 Euro. This lowers the barrier of entry and allows for efficient diversification with a relatively small portfolio. 

By expanding into real estate financing, we at Invesdor believe we can offer our investors the opportunity to earn dual returns. On the one hand, investors have the opportunity to earn a financial return. On the other, investors have the opportunity to earn a sustainable return stemming from both social and environmental sustainabilit

A Forward-Looking Example from Helsinki, Finland: The VALO Hotel & Work 

The VALO Hotel & Work   in Helsinki, Finland is considered a forward-looking example of sustainable real estate development in the city. The facility demonstrates how urban spaces can be used more efficiently and sustainably through intelligent usage concepts.

In traditional hotels many spaces remain unused during the day. In traditional offices many spaces remain unused during the night. VALO takes an entirely new approach: The same space can be used as a hotel and an office flexibly depending on the time of day. In the day the rooms can be used as fully equipped offices. In the evening the same rooms become comfortable hotel rooms. The transformation happens in minutes while the guest is having breakfast or dinner. This principle of double use applies throughout the entire building, significantly optimizing its usage, and ultimately lowering not only scope one and two emissions but also scope three emissions.  

Flexible Use and Digital Management for Greater Efficiency   

The rooms are designed so that the switch from working space to a hotel room can be done within minutes. Ergonomic desks, digital infrastructure, and ample storage ensure a productive work environment during the day. In the evening, the room becomes a cozy retreat. Booking is handled digitally, allowing visitors to decide spontaneously whether they want to use the space for work, for an overnight stay or both. 

Sustainable Real Estate Investment with High Impact   

Invesdor alumni VALO demonstrates how sustainable real estate can be both environmentally and economically profitable. Dual usage cuts operational costs and allows for energy and resource consumption optimization as less space is needed per person. 

This presents an attractive opportunity for investors: VALO proves that real estate projects can combine financial success with social and environmental responsibility. It serves as an example of sustainable real estate investments that are viable in the long term and address today’s challenges in the housing and labor markets. 

Future-Proof Cities Through Innovative Real Estate Concept 

VALO’s concept of dual use allows for shaping the future of urban development through real estate. VALO Hotel & Work connects hotel and working environments, reduces environmental impact, and creates flexible solutions for modern lifestyles. Concepts like VALO Hotel & Work are leading the change in making urban spaces more livable, adaptable, and sustainable – and show the potential of responsible investment in the field of real estate. 

Future-Oriented Logistics in Wiesau: The DFI Future Park Northern Bavaria 

Flexible use in the logistics center: adaptable spaces 

This logistics park in Northern Bavaria offers approximately 32,000 square meters of rental space, including production halls, storage units, and flexibly designed mezzanine levels. The logistics park is strategically locatied near the A93 highway, proxime to a freight transport hub, and within short distance of the Czech border. These aspects provide ideal conditions for efficient logistics operations. 

Investment security: targeted sales and leasing strategy 

A reputable institutional investor has already signed the purchase agreement for the logistics park. The leasing process has been outsourced to an experienced broker network. With construction still ongoing the project team is tailoring the spaces to meet the specific needs of future tenants. Completion is scheduled for 2026.  

Sustainable investment in the real estate sector: forward-looking logistics 

The DFI Zukunftspark  in upper Bavaria demonstrates how sustainable logistics properties combine financial- and environmental returns. As such this investment opportunity offers an attractive expected return for investors. 

Energy efficiency through digital retrofitting: metr in Berlin 

Berlin-based PropTech company metr provides a forward-looking example of sustainability in existing buildings. The company has developed an IoT platform that makes existing heating systems smarter and more efficient. In doing so, metr demonstrates how digital retrofitting can be a cost-effective alternative to comprehensive renovations – with a noticeable effect on energy consumption and emissions. 

Smart technology instead of expensive renovations 

Many heating systems in residential buildings still run on factory settings and are not optimally adapted to the needs of the residents. This is where metr comes in with its technology: the systems are equipped with sensors and a digital control system that automatically optimises operation. This means that energy is only used when it is really needed. 

Savings without compromising on comfort 

In several thousand buildings, metr has already proven that energy consumption can be reduced by up to 35 % . For residents, this means consistent comfort while reducing heating costs. For the real estate industry, this results in significant operating cost advantages – and a direct contribution to the decarbonisation of the building sector. 

Sustainable investment in digital solutions 

metr offers real estate companies a scalable way to make their portfolios more climate-friendly without having to invest in costly construction projects right away. For investors, the company provides an example of how technological innovation in the real estate sector can combine economic success with environmental impact. 

Sustainable real estate investments – a return for both the environment and investors 

Sustainable real estate investment opportunities can refer to both environmental and social returns while offering an attractive financial return to the investors. Ultimately allowing investors to actively contribute to sustainable development while earning financial returns. Real estate also provides investors the opportunity to diversify their portfolio into a new asset class with expected low correlation with other asset classes. 

Invesdor offers investment opportunities in real estate including: 

• newly developed and integrate state-of-the-art, resource-efficient technologies from the outset, 
• renovation of real estate to upgrade existing structures  in an efficient and sustainable way, 
• expansion of real estate to make better use of existing infrastructure in a more sustainable and efficient manner. 

Such investment opportunities meet a clear return criteria both from a financial and sustainable point of view.  

Real estate is regarded an attractive asset class as it is regarded comparatively stable with low correlation to other asset classes, such as stocks and bonds, allowing for diversification.  

Like with all (financial) assets also real estate is associated with risk. The risk is strongly dependent on the investment vehicle used for investing in real estate. In real estate backed debt the main risk to consider is the inability to serve the debt and the collateral pledged against this debt. The risk is that the (real estate) operator is unable to service (repay) the debt. They have a known return and risk. 

Info: How Invesdor evaluates investment opportunities 

We evaluate each investment opportunity through a clearly defined process to ensure an attractive risk-return relationship. Each investment opportunity evaluated in several stages: 

1. Initial Screening and Scoring: 
   A preliminary selection based on financial metrics, creditworthiness, and business model. 

2. In-Depth Analysis: 
   A detailed assessment of the legal framework and technical factors.  

3. ESG Evaluation: 
   A review to ensure both financial return potential and sustainable return potential is met (e.g., CO₂ footprint, social impact). 

4. Investment Committee: 
   The final decision is made by a panel of experts that consolidates all assessment results. 

Only about 5% of screened investment opportunities make it onto the Invesdor platform. 
 
You can find more details about the evaluation process for investment opportunities here.: Investment Evaluation Process.   

Invest Sustainably Now: Your Chance to Shape the Future!  

Investment opportunities in sustainable real estate can offer attractive financial returns while enabling investors to play an active role in addressing global challenges. Join the sustainable investment community on Invesdor today and discover attractive investment opportunities that combine financial- and sustainable return.  

Start today and invest in a future worth living! 
  
Here you can find our current investment opportunities.    

FAQ: Frequently Asked Questions from Potential Investors in Sustainable Real Estate  

The post Sustainable real estate investments: real estate as a key to a livable future  first appeared on Invesdor - Blog.

When and where to invest to your money

When many investors sell company shares due to the economic or political situation, the prices fall – and thus offer others a favourable entry opportunity. This is known as an anti-cyclical investment.

Countercyclical value investing is a popular strategy among long-term investors that allows them to profit from stocks or bonds that are undervalued due to market dislocations. In this way, investors capitalise on the fact that financial instruments are often oversold in bad times and therefore undervalued relative to their substance. As soon as market conditions improve, their prices should rise again, the idea goes.

Mari Lymysalo, Managing Director at Invesdor Nordics highlights: “The competition among investors for investments in start-ups and growth companies is significantly lower than before. That’s why growth companies in particular have fallen significantly in valuation due to the lack of venture capital.”

This scenario applies to many growth companies and opens enormous opportunities for investors in the areas of equity investments, venture capital and participation in growth companies in the upcoming year.

The hidden opportunities of private equity, venture capital and growth company investments

There are winners in every market phase. Even in crises or recessions, these can be successful start-ups or growth companies with a forward-looking business model and a well-thought-out business plan. These companies are also called growth companies.

“Selected growth companies offer investors excellent opportunities when it comes to investing in companies with attractive returns – this is where the expertise of specialists who know the markets and act professionally when it comes to selecting suitable growth companies for investment is needed,” explains Mari Lymysalo from Invesdor.

Invesdor always provides you with expertise for growth companies and venture capital. With us, you will only find pre-selected investments in which you can already get involved with smaller amounts.“

Participation in growth companies usually takes the form of venture capital or private equity investment. In both forms, the investors invest in the equity capital and thus obtain ownership shares in the growth company. Both forms of investment take place before the target company is listed on the stock exchange and thus share or bond investments on the stock exchange are not yet possible. They differ above all in the investment horizon and the investment structure. The goal of private equity investors is the exit through an IPO or the profitable sale of the company.

Growth companies have successfully mastered their start-up phase and are pursuing a forward-looking strategy with qualified management. However, these companies do not yet generate excessive profits with which they could finance further growth. They are dependent on financiers. Since banks continue to be reluctant to lend, the main option for growth companies is the participation of venture capital or private equity investors.

“Investments in this area are usually only accessible to institutional investors, especially since the minimum investment amount often exceeds the budget of private investors. However, Invesdor makes it possible to bundle the investments of interested investors and thus also transfer shares in growth companies to private individuals,” says Mari Lymysalo.  

For investments in growth companies, we at Invesdor are at your side to finance additional growth or to open up new markets. These growth companies offer excellent opportunities – but also risks that need to be calculated precisely. Our experts analyse the potential success of the growth companies. A growth company will be included in our project portfolio only if this assessment is positive.

Why growth companies are proven to be the best investments for 2025

The effects of numerous conflicts have marked the past years. Triggered by the energy crisis and the lack of supplies from Eastern Europe, Russia and the Middle East, fossil fuels and electricity prices rose sharply. Worldwide supply chains were interrupted or at least significantly restricted. This led to sharp price increases in all areas and thus high inflation.

In order to curb inflation, the central banks raised interest rates several times. The rising interest rates in turn led to a slump in the stock markets, which were only able to recover over the year partially. But the market’s overall momentum has slowed.

Mari Lymysalo, Managing Director at Invesdor Nordics explains it as: “The value of growth companies is based on future expectations. The value of these future cash flows decreases as interest rates rise. In the changed market environment, the valuation views of venture capitalists and growth companies have diverged, and it has taken some time for them to align,” says the venture capital investment expert.

Mari Lymysalo’s tips for investing in growth companies at a glance: 

• Define investment objectives 
• Spread across different asset classes and also within an asset class 
• Exploiting the opportunities of crowdfunding 
• Finding the right mix: a good business model with growth prospects 
• Be well-informed and make well-considered decisions 

Why invest with us?

The Invesdor Group has been active in the market for over 10 years and is at home in many European countries. Since then, we have become one of the largest financing and investment platforms on our continent. 

To date, more than 194,000 investors have invested over 550 million euros in European companies in more than 1000 projects. Fairness, collaboration and agility are the pillars of our corporate culture. In the areas of crowdinvesting and crowdlending, investors can participate in forward-looking companies with smaller amounts. 

As an awarded and innovative platform for crowdinvesting, our company is represented in five core countries in Europe. The focus is particularly on industries that deal with climate change and people’s health. With venture capital, we support these future industries and thus offer our clientele attractive entry opportunities. Private investors thus have the option of directly participating in growth companies that are not traded on any stock exchange.

Read also:
Learn all about how we select your investment opportunities
Fixed interest or equity investments – which type of return are you aiming for?

The post Growth companies: The best investments for 2025 first appeared on Invesdor - Blog.

Invesdor brings together innovative entrepreneurs and forward-thinking investors to accelerate the transition to a sustainable economy. Citizens are also regularly successfully involved in this transition where they can benefit from the returns of local projects. Windpark Fryslân’s starting point was to allow local residents to participate in the revenues from the wind farm in their own neighborhood. Together with Invesdor’s investment platform, Windpark Fryslân raised the overwhelming amount of €27 million from 2609 investors in a period of six weeks. This instantly made this project Europe’s largest crowdfunding initiative for renewable energy.

The post Invesdor organized Europe’s largest crowdfunding campaign for renewable energy first appeared on Invesdor - Blog.

‘That the world needs change is beyond question,’ says Invesdor CEO Christopher Grätz. He also emphasizes, ‘But it won’t change on its own – someone has to take action. And, above all, someone has to finance it.’ As a pan-European impact investing platform that emerged from the merger of several platforms from different European countries, Invesdor has focused on one key question: If the most significant progress in the world is made by adventurous, entrepreneurial individuals who have the courage to think differently, what if we gave this opportunity to everyone? The opportunity to decide what kind of future they want to pursue? The chance to choose which companies can bring about this change? And the chance to participate in financing it all?

At Invesdor, we believe that investors can shape their future by investing in companies they believe in. This forms the basis of our call to investors: Let’s finance the future together. People have long decided – as shown by societal trends in recent years – what this future should look like: more sustainable, more equal, and more responsible. ‘Sustainability is a huge market, with corresponding massive interest and investment capital,’ says Christopher Grätz.

With the merger with Oneplanetcrowd, Invesdor has positioned itself as a leading European impact investing platform: Oneplanetcrowd has long pursued a targeted impact strategy, focusing exclusively on projects that have a clear impact on one of the 17 United Nations Sustainable Development Goals (SDGs).

In the meantime, the entire Invesdor Group has set the goal of presenting investors exclusively with projects that contribute to a sustainable world of the future. To achieve this, we have formulated two essential sustainability guidelines:

1. All Invesdor issuers and their projects undergo an ESG risk assessment before being listed.
2. For all projects, the impact on at least one of the mentioned SDGs is determined through measurable Key Performance Indicators (KPIs). The ‘Oneplanet’ label highlights outstanding projects.

We take these guidelines very seriously – they have the same priority for us as credit risk policy does for loans and investment policy does for equity projects.

ESG: Responsible in Three Areas

ESG is one of the aspects at the core of Invesdor’s guidelines for sustainable investing. The abbreviation stands for Environmental, Social, and Governance and refers to the three central factors for measuring the sustainability of an investment. Environmental criteria (represented by the ‘E’ in ESG) address how a company contributes to solving environmental issues (e.g., waste, pollution, greenhouse gases, deforestation, and climate change). Social criteria (the ‘S’ in ESG) relate to the treatment of employees and customers by the respective company (e.g., human capital management, diversity and equal opportunity, working conditions, health, and safety as well as misleading sales). Governance criteria (the ‘G’) examine how a company is managed (e.g., executive compensation, tax practices and strategy, corruption and bribery, as well as diversity and structure).

The growing importance of ESG in finance is based on the simple idea that companies deliver high returns when they create value for their stakeholders – employees, customers, suppliers, and society as a whole – and not just for the company’s owners.

How Invesdor Assesses ESG Risks

The ESG analysis can be complex. When considering ESG factors, it is not only about evaluating the products and services of a company but also its behavior, its supply chain, and other aspects related to its corporate governance. As part of our ESG risk assessment, we investigate whether the company has negative impacts on sustainability factors such as environmental, social, and labor issues, respect for human rights, and the fight against corruption and bribery. In addition, we assess whether a company is exposed to serious sustainability risks, meaning an ecological, social, or governance event or condition that could significantly impair the value of the investment if it were to occur.

The goal of the ESG risk analysis is to identify both risks and opportunities and thus uncover potential areas for improvement. At Invesdor, we firmly believe that a more forward-looking and dynamic approach is needed when evaluating ESG risks and opportunities. Furthermore, an ideal analysis should not only consider the latest ESG data but also the company’s strategy, overall impact, and evidence that it adheres to its promises and standards. It should also include a forward-looking perspective, so that investment decisions are not based solely on historical data.

The ESG risk assessment is a free analysis that Invesdor conducts for every new project that is to be placed on the platform. The goal of this assessment is to answer the following two questions:

1. Does the project harm the environment, society, and/or stakeholders?
2. Could the value of this project be jeopardized by ESG developments?

If the answer to either of these questions is ‘Yes,’ the project will not be included on the Invesdor platform.

The table below contains some examples for each of the ESG criteria:

The 6 environmental objectives of the EU, as defined in the Taxonomy Regulation, are:

1. Mitigation of climate change,
2. Adaptation to climate change,
3. Sustainable use and protection of water and marine resources,
4. Transition to a circular economy,
5. Prevention and reduction of environmental pollution, and
6. Protection and restoration of biodiversity and ecosystems.

Impact: Doing Good – and How Invesdor Measures It

The potential of companies or projects in terms of impact investing is also part of Invesdor’s sustainability guidelines. Impact investing means investing in something that measurably contributes to one of the goals for sustainable development, the aforementioned SDGs. It is a form of sustainable investing that goes beyond simply excluding companies or countries. With impact investing, investors achieve not only financial returns but also a positive sustainable impact. ‘Invesdor decided to use the SDGs as a framework for determining intended and realized impacts,’ explains Christopher Grätz. The SDGs serve as a blueprint for addressing the biggest societal challenges of our time, such as combating diseases (SDG 3) and renewable energy (SDG 7). Together, the SDGs form a roadmap for achieving peace and prosperity for people and the planet, now and in the future. ‘Invesdor only awards the impact label to companies in the financial sector that make a positive contribution to at least one of the SDGs,’ says the Invesdor CEO.

Where Invesdor Draws Red Lines in Terms of ESG and SDGs

To emphasize that Invesdor does not compromise in certain areas, we have identified specific services, products, and sectors that are under no circumstances acceptable for the platform and thus cross the red lines. As such no-gos, Invesdor excludes projects from companies that:

• Are involved in the production, marketing, or sale of tobacco and cannabis products for recreational use.
• Are involved in the gambling industry or provide services in this sector.
• Manufacture weapons, specifically designed components for weapons, or provide weapons-related services. Companies involved in the production or sale of dual-use technologies. Dual-use technologies are subject to strict scrutiny, as their products must not be intended to inflict physical harm on humans or animals or contribute to such harm.
• Have a high risk of using conflict minerals or those who mine and supply such minerals without making efforts to source conflict-free minerals. Invesdor also requires this from its suppliers.
• Operate in the sex industry.
• Conduct animal testing that is only acceptable for legitimate medical purposes, and Invesdor does not place companies that do not conduct carefully controlled animal testing based on the principles of ‘reduce, refine, replace.’
• Use animal products or ingredients and do not have animal welfare policies and practices that go beyond legal requirements. We prefer companies that have clear goals for improving animal welfare and actively advocate for better animal welfare standards in the industry, as well as companies that offer plant-based alternatives for the production or use of animal products.
• Do not contribute to sustainable fishing and aquaculture practices.
• Are involved in the production and sale of fur and specialty leather for which animals are bred.
• Cause extensive or repeated damage to biodiversity or are in businesses with a high potential risk of causing such damage without managing these risks.
• Show no awareness of deforestation, do not practice sustainable forestry, and do not source and use responsible forestry products.
• Are unaware of climate change and do not make credible efforts to eliminate their greenhouse gas emissions and find alternatives to non-reducible emissions as quickly as possible.
• Are unaware of the dangers of using hazardous substances and do not contribute to the introduction, development, and promotion of less harmful alternatives.
• Are involved in accounting irregularities or irregularities in compensation that raise significant ethical and moral concerns.
• Offer excessive compensation and remuneration packages for directors that do not comply with local or international standards for best practices.
• Are involved in irregularities related to corruption, bribery, or money laundering.
• Engage in tax avoidance schemes that raise serious ethical or moral concerns and clearly violate local or international standards.
• Are involved in violations of laws and regulations, codes of conduct, or conventions, unless there are indications of structural change within the company that lead to fundamental behavioral changes.

We believe that with the Invesdor investment guidelines, we can contribute to perhaps the most pressing issue of our time: the transition to a more sustainable, equitable, and responsible economy.

The post Sustainability: How Invesdor Implements ESG, SDGs, and More first appeared on Invesdor - Blog.

Beets & Roots in a nutshell  

beets&roots is a German fast-casual restaurant chain that offers healthy and environmentally friendly food. Beets & Roots GmbH was founded in 2016 in Berlin by entrepreneur Max Kochen and Michelin star chef Andreas Tuffentsammer to meet the need for healthy lunch options for busy people.  

Today, beets&roots has 16 restaurants across Germany. With Beets & Roots GmbH’s latest successful funding round at Invesdor, they plan on opening three more restaurants at the main train stations in Berlin, Cologne and Hamburg. In an interview from 2023 Max Kochen outlines beets&roots growth journey after previous funding rounds with Invesdor. 

Opportunity to higher returns on investment 

Beets & Roots GmbH has raised a total of five funding rounds on Invesdor’s platform (see chart for more information).  In the latest funding round, beets&roots experienced exponential growth, more than doubling its turnover and attracting over 1.5 million euros from investors across Europe. With each round, investors were not only drawn by the financial opportunities but also by enticing bonuses, including up to 50% discounts on orders, enriching their investment experience. 

For the first time Beets & Roots GmbH’s funding round was offered on all Invesdor websites: Germany, Austria, Finland, the Netherlands, and the English website welcoming investors from all over Europe. Previous rounds have only been open to investors in Germany and Austria. 

Beets & Roots GmbH has chosen different financial instruments for their funding rounds throughout the years. This demonstrates well how growth companies and investors benefit from the different financial instruments Invesdor has to offer.  

In their last round in January 2024 Beets & Roots GmbH decided to raise equity. Equity investments offer investors a stake in the target company allowing the investors to reap the full potential upside in the company. As Beets & Roots GmbH is aiming for an exit in 2026, the investors have the opportunity to earn a substantial return on their investment in the coming 36 months. 

Make an impact with your choices 

By investing in innovative and sustainable businesses, investors do not have the opportunity for a financial return but also make an impact by helping companies like Beets & Roots GmbH drive sustainability and a better future for Europe. Read more about Invesdor’s commitment to impact investing. 

Beets & Roots GmbH is committed to drive sustainability in all parts of their business. In practice, they source most of their ingredients from local suppliers and promote sustainable farming practices by working with Klim.  

As a consumer you can be at the forefront of change for a sustainable future of Europe by choosing a plant-based alternative to meat and opt for reusable takeaway packaging. 

As an investor you can be at the forefront of change for a sustainable future of Europe by investing in companies driving sustainability in their operations. Your choice matters! 

If you want to stay informed about upcoming investment opportunities, sign up for our newsletter and follow us on our social media channels.  

The post Beets & Roots is an investor favorite at Invesdor first appeared on Invesdor - Blog.